Logo image of OSTK

OVERSTOCK.COM INC (OSTK) Stock Fundamental Analysis

NASDAQ:OSTK - Nasdaq - US6903701018 - Common Stock - Currency: USD

16.78  +0.87 (+5.47%)

After market: 17 +0.22 (+1.31%)

Fundamental Rating

2

Taking everything into account, OSTK scores 2 out of 10 in our fundamental rating. OSTK was compared to 121 industry peers in the Specialty Retail industry. The financial health of OSTK is average, but there are quite some concerns on its profitability. OSTK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OSTK had negative earnings in the past year.
OSTK had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OSTK reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: OSTK reported negative operating cash flow in multiple years.
OSTK Yearly Net Income VS EBIT VS OCF VS FCFOSTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M -100M 200M -200M 300M

1.2 Ratios

With a Return On Assets value of -16.97%, OSTK is not doing good in the industry: 81.68% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -24.00%, OSTK is doing worse than 64.12% of the companies in the same industry.
Industry RankSector Rank
ROA -16.97%
ROE -24%
ROIC N/A
ROA(3y)11.65%
ROA(5y)-7.67%
ROE(3y)18.42%
ROE(5y)-41.02%
ROIC(3y)N/A
ROIC(5y)N/A
OSTK Yearly ROA, ROE, ROICOSTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -50 -100 -150

1.3 Margins

OSTK has a worse Gross Margin (22.84%) than 75.57% of its industry peers.
OSTK's Gross Margin has improved in the last couple of years.
OSTK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5Y3.32%
OSTK Yearly Profit, Operating, Gross MarginsOSTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20

More info and screens

5

2. Health

2.1 Basic Checks

OSTK does not have a ROIC to compare to the WACC, probably because it is not profitable.
OSTK has more shares outstanding than it did 1 year ago.
The debt/assets ratio for OSTK is higher compared to a year ago.
OSTK Yearly Shares OutstandingOSTK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
OSTK Yearly Total Debt VS Total AssetsOSTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.2 Solvency

OSTK has an Altman-Z score of 3.78. This indicates that OSTK is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.78, OSTK belongs to the top of the industry, outperforming 80.15% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that OSTK is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.06, OSTK is in the better half of the industry, outperforming 74.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 3.78
ROIC/WACCN/A
WACC9.19%
OSTK Yearly LT Debt VS Equity VS FCFOSTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 200M 400M 600M

2.3 Liquidity

OSTK has a Current Ratio of 1.97. This is a normal value and indicates that OSTK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.97, OSTK is in the better half of the industry, outperforming 77.86% of the companies in the same industry.
OSTK has a Quick Ratio of 1.94. This is a normal value and indicates that OSTK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.94, OSTK belongs to the top of the industry, outperforming 87.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.94
OSTK Yearly Current Assets VS Current LiabilitesOSTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

More info and screens

1

3. Growth

3.1 Past

OSTK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -102.27%.
OSTK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -42.51%.
The Revenue has been growing slightly by 2.03% on average over the past years.
EPS 1Y (TTM)-102.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-110.53%
Revenue 1Y (TTM)-42.51%
Revenue growth 3Y10.37%
Revenue growth 5Y2.03%
Sales Q2Q%-60.32%

3.2 Future

The Earnings Per Share is expected to grow by 12.97% on average over the next years. This is quite good.
OSTK is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.93% yearly.
EPS Next Y-352.74%
EPS Next 2Y-106.12%
EPS Next 3Y-22.55%
EPS Next 5Y12.97%
Revenue Next Year-19.05%
Revenue Next 2Y-6.61%
Revenue Next 3Y-2.73%
Revenue Next 5Y-0.93%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OSTK Yearly Revenue VS EstimatesOSTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
OSTK Yearly EPS VS EstimatesOSTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OSTK. In the last year negative earnings were reported.
Also next year OSTK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSTK Price Earnings VS Forward Price EarningsOSTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OSTK is valued a bit more expensive than 65.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 48.99
OSTK Per share dataOSTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A cheap valuation may be justified as OSTK's earnings are expected to decrease with -22.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-106.12%
EPS Next 3Y-22.55%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OSTK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OVERSTOCK.COM INC

NASDAQ:OSTK (11/3/2023, 8:14:30 PM)

After market: 17 +0.22 (+1.31%)

16.78

+0.87 (+5.47%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)10-26 2023-10-26/bmo
Earnings (Next)02-20 2024-02-20/amc
Inst Owners63.52%
Inst Owner Change-0.25%
Ins Owners4.25%
Ins Owner Change0%
Market Cap760.13M
Analysts71.76
Price Target22.95 (36.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.31%
Min EPS beat(2)36.41%
Max EPS beat(2)78.21%
EPS beat(4)3
Avg EPS beat(4)-38.5%
Min EPS beat(4)-296.08%
Max EPS beat(4)78.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.78%
Min Revenue beat(2)1.03%
Max Revenue beat(2)4.52%
Revenue beat(4)2
Avg Revenue beat(4)-2.64%
Min Revenue beat(4)-11.53%
Max Revenue beat(4)4.52%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-41.05%
PT rev (3m)-47.27%
EPS NQ rev (1m)-10.42%
EPS NQ rev (3m)-154.86%
EPS NY rev (1m)5.79%
EPS NY rev (3m)-76.5%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-4.01%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)-2.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.4
EV/EBITDA 48.99
EPS(TTM)-0.03
EYN/A
EPS(NY)-1.15
Fwd EYN/A
FCF(TTM)-1.3
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS36.83
BVpS12.65
TBVpS11.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.97%
ROE -24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.84%
FCFM N/A
ROA(3y)11.65%
ROA(5y)-7.67%
ROE(3y)18.42%
ROE(5y)-41.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5Y3.32%
F-Score3
Asset Turnover2.06
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA 3.7
Cap/Depr 230.01%
Cap/Sales 2.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.97
Quick Ratio 1.94
Altman-Z 3.78
F-Score3
WACC9.19%
ROIC/WACCN/A
Cap/Depr(3y)74.77%
Cap/Depr(5y)83.05%
Cap/Sales(3y)0.68%
Cap/Sales(5y)1.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-102.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-110.53%
EPS Next Y-352.74%
EPS Next 2Y-106.12%
EPS Next 3Y-22.55%
EPS Next 5Y12.97%
Revenue 1Y (TTM)-42.51%
Revenue growth 3Y10.37%
Revenue growth 5Y2.03%
Sales Q2Q%-60.32%
Revenue Next Year-19.05%
Revenue Next 2Y-6.61%
Revenue Next 3Y-2.73%
Revenue Next 5Y-0.93%
EBIT growth 1Y-111.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-264.4%
EBIT Next 3Y3.2%
EBIT Next 5Y17.06%
FCF growth 1Y-151.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.08%
OCF growth 3YN/A
OCF growth 5YN/A